# Filing Detail

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-19-043217
Filing Date
2019-02-19
Accepted
2019-02-19 06:04:07
Documents
22
Period of Report
2019-02-18

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 6-K | d671652d6k.htm | 6-K | 30624
2 | GRAPHIC | g671652g0218070256150.jpg | GRAPHIC | 8035
3 | GRAPHIC | g671652txs10g1.jpg | GRAPHIC | 198734
4 | GRAPHIC | g671652txs11g1.jpg | GRAPHIC | 214473
5 | GRAPHIC | g671652txs12g1.jpg | GRAPHIC | 329308
6 | GRAPHIC | g671652txs13g1.jpg | GRAPHIC | 186204
7 | GRAPHIC | g671652txs14g1.jpg | GRAPHIC | 242149
8 | GRAPHIC | g671652txs15g1.jpg | GRAPHIC | 249852
9 | GRAPHIC | g671652txs16g1.jpg | GRAPHIC | 193996
10 | GRAPHIC | g671652txs17g1.jpg | GRAPHIC | 213441
11 | GRAPHIC | g671652txs18g1.jpg | GRAPHIC | 194832
12 | GRAPHIC | g671652txs19g1.jpg | GRAPHIC | 183931
13 | GRAPHIC | g671652txs20g1.jpg | GRAPHIC | 270100
14 | GRAPHIC | g671652txs21g1.jpg | GRAPHIC | 213523
15 | GRAPHIC | g671652txs22g1.jpg | GRAPHIC | 265616
16 | GRAPHIC | g671652txs23g1.jpg | GRAPHIC | 70732
17 | GRAPHIC | g671652txs4g1.jpg | GRAPHIC | 196146
18 | GRAPHIC | g671652txs5g1.jpg | GRAPHIC | 317994
19 | GRAPHIC | g671652txs6g1.jpg | GRAPHIC | 265321
20 | GRAPHIC | g671652txs7g1.jpg | GRAPHIC | 284623
21 | GRAPHIC | g671652txs8g1.jpg | GRAPHIC | 201547
22 | GRAPHIC | g671652txs9g1.jpg | GRAPHIC | 216770
| Complete submission text file | 0001193125-19-043217.txt |  | 6255669

Mailing Address LEVEL 5 20 GEORGE STREET HORNSBY NSW C3 2077
Business Address LEVEL 5 20 GEORGE STREET HORNSBY NSW C3 2077 01161298780088
KAZIA THERAPEUTICS LTD (Filer) CIK: 0001075880 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 000-29962 | Film No.: 19613203
SIC: 2834 Pharmaceutical Preparations